Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shao-Chin Chiang"'
Publikováno v:
Breast, Vol 51, Iss , Pp 57-64 (2020)
Background: New developments in medications for metastatic breast cancer (MBC) can be of great benefit to patients, but unfortunately these medicines also increase expenditures. Cost-utility analyses (CUAs) are needed to allocate health resources pro
Externí odkaz:
https://doaj.org/article/5bac007817c24c41ac0ea0df4df3590b
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257873 (2021)
Closed-system drug transfer devices (CSTDs) are used to prevent occupational exposure to hazardous drugs in health care providers. They are considered Class II medical devices by the US FDA and are cleared but not approved before marketing. While com
Externí odkaz:
https://doaj.org/article/b780054f1752427db2aa00c0a52269b7
Autor:
Pei-Pei Huang, Samantha Yun-Kai Poon, Shao-Hsuan Chang, Chien-Wen Kuo, Ming-Wen Chien, Chien-Chih Chen, Shao-Chin Chiang
Publikováno v:
International Journal of General Medicine. 16:211-220
Pei-Pei Huang,1,* Samantha Yun-Kai Poon,2,* Shao-Hsuan Chang,3 Chien-Wen Kuo,4 Ming-Wen Chien,1 Chien-Chih Chen,5 Shao-Chin Chiang2,6 1Division of Outpatient Pharmacy, Department of Pharmacy, Cheng Hsin General Hospital, Taipei, Taiwan; 2Depa
Publikováno v:
Breast, Vol 51, Iss, Pp 57-64 (2020)
The Breast : official journal of the European Society of Mastology
The Breast : official journal of the European Society of Mastology
Background New developments in medications for metastatic breast cancer (MBC) can be of great benefit to patients, but unfortunately these medicines also increase expenditures. Cost-utility analyses (CUAs) are needed to allocate health resources prop
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257873 (2021)
PLoS ONE
PLoS ONE
Closed-system drug transfer devices (CSTDs) are used to prevent occupational exposure to hazardous drugs in health care providers. They are considered Class II medical devices by the US FDA and are cleared but not approved before marketing. While com
Publikováno v:
Healthcare, Vol 9, Iss 1600, p 1600 (2021)
Healthcare; Volume 9; Issue 11; Pages: 1600
Healthcare
Healthcare; Volume 9; Issue 11; Pages: 1600
Healthcare
Despite the first approval of biosimilars’ in 2010, biosimilar products usage has remained low in Taiwan. This cross-sectional survey study assessed healthcare professionals’ (HCPs)—hospital pharmacists, oncologists, and rheumatologists—knowl
Publikováno v:
Medicine
To determine the economic burden of metastatic breast cancer (MBC) in Taiwan, we conducted a national retrospective claim database analysis to evaluate the incremental healthcare costs and utilization of MBC patients as compared to their breast cance
Publikováno v:
Cancer Nursing. 36:198-205
Background Several studies have documented the efficacy of prophylactic granulocyte colony-stimulating factor in reducing rates of infections and risk of febrile neutropenia. An appropriate risk assessment model is pivotal to identify high-risk patie
Autor:
Yu-Wen Wen, Tsun Jen Wen, Li-Jiuan Shen, Shao Chin Chiang, Fei-Yuan Hsiao, Chun Ru Chien, William W. Y. Hsu
Publikováno v:
Journal of evaluation in clinical practice. 23(2)
Rationale, aim and objective The beneficial effects of granulocyte colony-stimulating factor (G-CSF) prophylaxis on reducing the risk of chemotherapy-induced febrile neutropenia (CIFN) were well documented throughout the literature. However, existing
Publikováno v:
Cancer Nursing; 2015 Supplement 4, Vol. 38, pS91-S91, 1/3p